Reference : The veno-occlusive disease of the liver.
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/6964
The veno-occlusive disease of the liver.
English
Baron, Frédéric mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
Deprez, Manuel [Université de Liège - ULg > Département des sciences cliniques > Neuropathologie >]
Beguin, Yves mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
1997
Haematologica
Ferrata Storti Foundation
82
6
718-25
Yes (verified by ORBi)
International
0390-6078
1592-8721
Pavia
Italy
[en] Bone Marrow Transplantation/adverse effects ; Diagnosis, Differential ; Hepatic Veno-Occlusive Disease/diagnosis/etiology/physiopathology/therapy ; Humans ; Risk Factors
[en] BACKGROUND AND OBJECTIVE: The veno-occlusive disease of the liver (VOD) is a disorder caused by the non-thrombotic occlusion of the central veins of hepatic lobules. The clinical features are similar to those of intrahepatic portal hypertension (unexplained weight gain, ascites, painful hepatomegaly, jaundice). In the past, this disease was rather infrequent and was linked to the absorption of toxic agents, liver irradiation or chemotherapy. However, the intensification of treatment protocols before hematopoietic stem cell transplants has considerably increased its incidence. The strategies used for its prevention and treatment remain limited in efficacy. The present review was undertaken in order to assess progress in the diagnosis and management of this severe complication in stem cell transplantation. INFORMATION SOURCES: The method used for preparing this review was an examination of 250 relevant articles or abstracts published in journals covered by Medline. STATE OF ART: Despite the progress made toward the understanding of its physiopathology and the identification of its risk factors, VOD is still one of the leading causes of morbidity and mortality during the first two months post-BMT, and therefore often constitutes a limitation for the further increment of the dose of antineoplastic drugs. This may be explained by the difficulty in making an early diagnosis of this problem, at a time when therapeutic intervention may be more effective, and, on the other hand, the lack of a well-established prevention and treatment approach for patients with VOD. PERSPECTIVES AND CONCLUSIONS: New diagnostic procedures, such as laparoscopic liver biopsy, and new therapeutic approaches, such as transjugular intrahepatic portosystemic shunting (TIPS) or defibrotide, are now being evaluated. However, additional studies will be needed to determine the most appropriate therapy for each VOD patient depending on the severity of the disease.
http://hdl.handle.net/2268/6964
also: http://hdl.handle.net/2268/62754

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
VOD.Haematologica.pdfNo commentaryPublisher postprint110 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.